NDAs submitted to the FDA for the first oral GLP-1 receptor agonist
Novo Nordisk has submitted NDAs for what could be the first ever oral...
Focus:
-
![Cell and gene therapy manufacturing 2019]()
Governments are playing a bigger role in cell and gene therapy manufacturing
-
![pharmaceutical supply chain]()
James MacKenzie Q&A: How late-stage packaging customisation is shaking up the pharmaceutical supply chain
-
![pharmaceutical industry in india]()
Northern India manufacturing on growth trajectory, but still lags behind south
-
![China pharma investment]()
Weighing national security vs foreign investment as Chinese funding of US bio/pharma soars
-
![improving IVF outcomes]()
Obseva’s nolasiban aims to address unmet need by improving IVF outcomes
-
![RegeneRx opthatlmic drug china]()
Lee’s Pharm and RegeneRx develop ophthalmic drug in China
Most Read
- James MacKenzie Q&A: How late-stage packaging customisation is shaking up the pharmaceutical supply chain
- Obseva’s nolasiban aims to address unmet need by improving IVF outcomes
- Lee’s Pharm and RegeneRx develop ophthalmic drug in China
- Pharma Technology Focus: the absence of antivenom in pharma
- FDA announces another carcinogenic impurity in ARB blood pressure drugs
Company A-Z
Latest Content
NDAs submitted to the FDA for the first oral GLP-1 receptor agonist
Novo Nordisk has submitted NDAs for what could be the first ever oral GLP-1 based treatment for type II diabetes. What could this mean for the GLP-1 market?
What Does Poor Quality Cost?
'The cost of quality' is a simple statement and yet few companies in the pharmaceutical manufacturing industry are paying close enough attention to this concept.
CPI Wet Granulation Manufacturing Facility, Durham, UK
In April 2019, Centre for Process Innovation (CPI) announced plans to develop a wet granulation manufacturing facility in Durham, UK.
Governments are playing a bigger role in cell and gene therapy manufacturing
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s Contract Service Provider Database.
Bioprocess Control Station
Distek has revolutionised benchtop-scale bioreactors with the release of its BIOne bioprocess control station for both mammalian and microbial models.
Innovation in asthma pipeline is focused on targeted biologic therapies
There is a much more diverse range of molecule types present in the asthma pipeline when compared to the current market space.
Quali®-V-I Hard Two-Piece HPMC Capsules for Inhalation
Inhalation delivery offers significant and unique benefits in the treatment of a variety of illnesses.
James MacKenzie Q&A: How late-stage packaging customisation is shaking up the pharmaceutical supply chain
Tablets in blisters may seem like a simple, everyday item, but in reality the manufacturing process is highly sophisticated. The trend toward smaller batch sizes and higher numbers of packaging variants is driving many manufacturers to turn to ‘postponement’ to improve the efficiency of their supply chains.
Northern India manufacturing on growth trajectory, but still lags behind south
Approximately 70% of all Indian pharmaceutical revenues will be from generics and revenue growth for this segment has been particularly rapid in recent years.
Merck’s Biotech Manufacturing Facility Expansion, Aubonne, Switzerland
In March 2019, Merck announced plans to expand its biotech manufacturing facility in Aubonne, Switzerland.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top
